A total of 35 studies investigated CD4+ T cells in HBV-associated HCC, of which 25 studies included circulating CD4+ T cells in PBMCs and 24 studies included infiltrating CD4+ T cells in liver tissue samples. The gene discussed is CD4; the disease is hepatocellular carcinoma.